
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems
Keywords: CI; Confidence interval; CT; Computed Tomography; DVT; Deep Vein Thrombosis; FDG PET/CT; 18F-Fluorodesoxyglucose Positron-Emission-Tomography combined with Computed-Tomography.; ICER; Incremental-cost effectiveness ratios; INB; Incremental net benefit; IT